Comparison of Albumin and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138706281217N4

Enrollment

Registered

2013-07-21

Start date

2009-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovariab hyperstimulation. ?????? ??? ????? ?? ?????? ??????-??????

Interventions

Intervention 1: using of cabergulin and albumin. Intervention 2: administration of cabergulin and alnumin.

Treatment - Drugs

using of cabergulin and albumin

administration of cabergulin and alnumin

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The inclusion criterion was the presence of >20 oocytes during oocyte retrieval, ovary size>10 cm, serum Estradiol >2500 pg/ml on the day of HCG administration.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Prevention of OHSS. Timepoint: from strat to 2 months later. Method of measurement: questionare.	—

Secondary

Measure	Time frame
Severity of OHSS. Timepoint: from start to 15 days later. Method of measurement: questionare.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Vahidroodsari

Montaserieh Ifertility center, Mashhad University of Medical Sciences

sabalanmountain@yahoo.com+98 51 1841 2477

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026